Variant spectrum of von Hippel–Lindau disease and its genomic heterogeneity in Japan
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddad039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Kenji Tamura und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Kochi Medical School, Kochi University, Nankoku, Japan. Hauptthemen laut MEDLINE: von Hippel-Lindau Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Von Hippel–Lindau (VHL) disease is an autosomal dominant, inherited syndrome with variants in the VHL gene, causing predisposition to multi-organ neoplasms with vessel abnormality. Germline variants in VHL can be detected in 80–90% of patients clinically diagnosed with VHL disease. Here, we summarize the results of genetic tests for 206 Japanese VHL families, and elucidate the molecular mechanisms of VHL disease, especially in variant-negative unsolved cases. Of the 206 families, genetic diagnosis was positive in 175 families (85%), including 134 families (65%) diagnosed by exon sequencing (15 novel variants) and 41 (20%) diagnosed by multiplex ligation-dependent probe amplification (MLPA) (one novel variant). The deleterious variants were significantly enriched in VHL disease Type 1. Interestingly, five synonymous or non-synonymous variants within exon 2 caused exon 2 skipping, which is the first report of exon 2 skipping caused by several missense variants. Whole genome and target deep sequencing analysis were performed for 22 unsolved cases with no variant identified and found three cases with VHL mosaicism (variant allele frequency: 2.5–22%), one with mobile element insertion in the VHL promoter region, and two with a pathogenic variant of BAP1 or SDHB. The variants associated with VHL disease are heterogeneous, and for more accuracy of the genetic diagnosis of VHL disease, comprehensive genome and DNA/RNA analyses are required to detect VHL mosaicism, complicated structure variants and other related gene variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Kochi Medical School, Kochi University, Nankoku, Japan.
- RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
- Department of Urology, Akita University Graduate School of Medicine, Akita 010-8543, Japan.
Zitieren
APA
Tamura, K., Kanazashi, Y., Kawada, C., Sekine, Y., Maejima, K., Ashida, S., Karashima, T., Kojima, S., Parrish, N. F., Kosugi, S., Terao, C., Sasagawa, S., Fujita, M., Johnson, T. A., Momozawa, Y., Inoue, K., Shuin, T., & Nakagawa, H. (2023). Variant spectrum of von Hippel–Lindau disease and its genomic heterogeneity in Japan. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad039
Vancouver
Tamura K, Kanazashi Y, Kawada C, Sekine Y, Maejima K, Ashida S, et al. Variant spectrum of von Hippel–Lindau disease and its genomic heterogeneity in Japan. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad039
BibTeX
@article{Tamura2023,
author = {Tamura, Kenji and Kanazashi, Yuki and Kawada, Chiaki and Sekine, Yuya and Maejima, Kazuhiro and Ashida, Shingo and Karashima, Takashi and Kojima, Shohei and Parrish, Nickolas F and Kosugi, Shunichi and Terao, Chikashi and Sasagawa, Shota and Fujita, Masashi and Johnson, Todd A and Momozawa, Yukihide and Inoue, Keiji and Shuin, Taro and Nakagawa, Hidewaki},
title = {Variant spectrum of von Hippel–Lindau disease and its genomic heterogeneity in Japan},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddad039}
}
EUVIMED